Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 134.50
-0.50 (-0.37%)
Sep 8, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 16.3 billion as of September 4, 2026. Its market cap has increased by 30.35% in one year.
Market Cap
16.30B
Enterprise Value
14.78B
Revenue
42.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
134.50
ChartMarket Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 16.30B, an increase of 83.87%. That is a compound annual growth rate of 6.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 16.30B | 54.42% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 21.87B |
| CHO Pharma | 21.51B |
| Sunmax Biotechnology | 21.46B |
| Medigen Vaccine Biologics | 20.94B |
| TaiMed Biologics | 17.13B |
| Ever Supreme Bio Technology | 15.61B |
| EirGenix | 14.19B |
| Lumosa Therapeutics | 13.35B |